Earnings Feed
Start Free
|4Jan 6, 5:49 PM ET

BIO-TECHNE Corp 4

4 · BIO-TECHNE Corp · Filed Jan 6, 2016

Insider Transaction Report

Form 4
Period: 2016-01-04
BIO-TECHNE CorpTECH
Gould Kevin S
SVP Clinical Controls
Transactions
  • Award

    Stock Options (Right to buy)

    2016-01-04+10,000→ 10,000 total
    Exercise: $88.23Exp: 2023-01-04→ Common Stock (10,000 underlying)
Holdings

  • Stock Options (Right to buy)

    Exercise: $97.23Exp: 2022-07-09→ Common Stock (50,000 underlying)
    50,000

  • Common Stock

    2,500

  • Stock Options (Right to buy)

    Exercise: $97.23Exp: 2022-07-09→ Common Stock (15,000 underlying)
    15,000
Footnotes (4)
  • [F1]Represents 2,500 restricted stock units that vest in increments of 833 shares on 07/09/16 and 07/09/17 and 834 shares on 07/09/18.
  • [F2]Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.
  • [F3]50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
  • [F4]Vests as to 3,750 shares on each of 07/09/16, 07/09/17, 07/09/18 and 07/09/19.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT